Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic.
Cervical cancer
Covid-19
Hypofractionation
Radiotherapy
Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
18
04
2020
revised:
03
05
2020
accepted:
17
05
2020
pubmed:
1
6
2020
medline:
7
8
2020
entrez:
1
6
2020
Statut:
ppublish
Résumé
Cervical cancer is a deadly disease and the COVID-19 pandemic has the potential to further impact its lethality. Hypofractionated radiotherapy could mitigate this impact, however robust data in cervical cancer setting still is lacking. Information provided here could help institutions in reducing radiotherapy fractions for cervical cancer patients.
Identifiants
pubmed: 32474128
pii: S0167-8140(20)30288-7
doi: 10.1016/j.radonc.2020.05.032
pmc: PMC7255703
pii:
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
270-273Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Références
Radiother Oncol. 2016 Sep;120(3):428-433
pubmed: 27134181
Int J Gynecol Cancer. 2013 May;23(4):592-7
pubmed: 23615570
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1154-9
pubmed: 15519787
Clin Oncol (R Coll Radiol). 2018 Jan;30(1):e29-e36
pubmed: 28988891
Front Oncol. 2016 Jun 28;6:160
pubmed: 27446806
Indian J Cancer. 2002 Oct-Dec;39(4):127-34
pubmed: 12928570
J Clin Oncol. 2018 Aug 20;36(24):2538-2544
pubmed: 29989857
Clin Transl Radiat Oncol. 2020 Mar 24;22:55-68
pubmed: 32274425
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Clin Transl Radiat Oncol. 2018 Jan 11;9:48-60
pubmed: 29594251